"Michael Douglas Has Throat Cancer"
Dr. Eric M. Genden, the chairman of the Department of Otolaryngology and an associate professor of Otolaryngology-Head and Neck Surgery, and Immunobiology at Mount Sinai, was a guest on Fox 5 News to discuss throat cancer.
Academy Award winner Michael Douglas has throat cancer, according to People magazine. His spokesperson said the actor, who will undergo chemotherapy and radiation, expects to make a full recovery. Dr. Eric M. Genden, the chairman of the Department of Otolaryngology and an associate professor of Otolaryngology-Head and Neck Surgery, and Immunobiology at Mount Sinai, was a guest on Fox 5 News to discuss throat cancer. Learn More
- Dr. Eric M. Genden, Professor & Chair, Otolaryngology, Chief of Head and Neck Oncology, The Mount Sinai Medical Center
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.